News

The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant Novo Nordisk to search for treatments controlling food intake and other factors contributing to obesity.  Under the joint project, EraCal and Novo Nordisk will research targets for obesity treatments by identifying molecules that can control appetite and improve metabolic health.
0 Comments
Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require viable cells, a demand often torpedoed by sample logistics. Eva Raschke, Director of Scientific Affairs at Precision for Medicine What do cancer, autoimmune diseases, and Covid-19 have in common? Hint: Think of immune cells. In immuno-oncology, therapeutic approaches provoke a
0 Comments
Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and co-founder of Qubit Pharmaceuticals, discusses the potential of physics to accelerate drug discovery.  Paris-based Qubit Pharmaceuticals was established in 2020 to commercialize the work of leading researchers in the computational chemistry space. This field uses computer modeling to predict how
0 Comments
A team of French organizations led by the biotech firm Antabio has launched a €17M project to deploy therapeutic, diagnostic, and economic innovations in the battle against antibiotic resistance. The project, dubbed ARPEGE, involves four partners covering a variety of disciplines: the antibiotics developer Antabio; the diagnostics heavyweight bioMérieux; the university hospital group Hospices Civils
0 Comments
This article will be freely available to view in February 2022. Labiotech members have exclusive access before it is unlocked. December 2021 ended with a bang for biotech funding in Europe and Israel, with cultured meat and cell therapy startups attracting the biggest investment rounds. Biotech companies in Europe and Israel capped off 2021 with a
0 Comments
As medical institutions develop the infrastructure for decentralized manufacturing of cell therapies, they are positioned to outperform big pharma’s limited success with a centralized approach to manufacturing. A revolution is coming in the discovery, development and delivery of living medicines. This revolution is being led by well-funded, elite academic medical centers, such as the University
0 Comments
The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray by launching the UK immuno-oncology company Adrendra Therapeutics. This happens as US investors increasingly search for value-for-money opportunities in early-stage European biotech startups. Last week, the life science-focused investor ATP contributed €47M (£40M) to the Series A launch of immunotherapy
0 Comments
In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021. The year 2021 has seen skyrocketing fortunes for many European biotech players. Investment firms, for instance, raised far more funding than in 2020, which
0 Comments
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle disease generalized myasthenia gravis, opening up its developer argenx to billion-dollar revenues. Efgartigimod, to be marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval
0 Comments
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European biotech is growing steadily and this year we welcome a few new names to the list of billion-euro biotechs. However, we also had to say goodbye to some of them, including Cellectis, Autolus, and Orchard
0 Comments
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited crops with the help of artificial intelligence tools. The firm expects to bring its first product, a weather-resistant tomato, to market in early 2022. The seed financing will fuel the development of Phytoform’s precision crop breeding platform, which specializes in
0 Comments
The US venture capital firm Apple Tree Partners (APT) is making its first transatlantic foray by launching the UK immuno-oncology company Adrendra Therapeutics. This happens as US investors increasingly search for value-for-money opportunities in early-stage European biotech startups. Last week, the life science-focused investor APT contributed €47M (£40M) to the Series A launch of immunotherapy
0 Comments
A €375M IPO from Evotec was the highlight of European biotech investments in November, with other cash going to firms working on cell therapy reprogramming and immuno-oncology. The total biotech investment haul for European companies reached €1.2B in November, with 41 deals in the bag. These deals included European and Israeli companies launching a private
0 Comments